The Effect of Dipeptidyl Peptidase 4 Inhibition on Growth Hormone Secretion in Women With Polycystic Ovarian Syndrome
Phase of Trial: Phase IV
Latest Information Update: 16 Dec 2016
At a glance
- Drugs Sitagliptin (Primary)
- Indications Cardiovascular disorders; Diabetes mellitus
- Focus Therapeutic Use
- 31 Oct 2016 Planned End Date changed from 1 Dec 2017 to 1 Jan 2018.
- 31 Oct 2016 Planned primary completion date changed from 1 Dec 2017 to 1 Jan 2018.
- 02 Feb 2016 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.